BDBM324809 9-(4-(2H-1,2,3-triazol-2-::US10189841, Compound I-15::US10399980, Compound I-15

SMILES CC(C)Oc1cc(F)ccc1-c1ncc2[nH]c(=O)n(Cc3ccc(cc3)-n3nccn3)c2n1

InChI Key InChIKey=TZYDFUSRSPJZKB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 324809   

TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Forma Therapeutics

US Patent
LigandPNGBDBM324809(9-(4-(2H-1,2,3-triazol-2- | US10189841, Compound I...)
Affinity DataIC50: >2.00E+3nMAssay Description:The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Forma Therapeutics

US Patent
LigandPNGBDBM324809(9-(4-(2H-1,2,3-triazol-2- | US10189841, Compound I...)
Affinity DataIC50: <0.00200nMAssay Description:The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent